Xeloda

Active ingredient
Capecitabin
Pharma Company
Roche Pharma AG/ Roche Deutschland Holding GmbH
Total Number of Doctors1
537 doctors
Total Number of Patients2
3,117 patients
Total minimum fees planned3
809,925.00 €

Observational Studies including Xeloda

Drug No. of doctors1 No. of patients2 Payment per patient3
Xeloda 161 1,270 450.00 € Meldung vor Anzeigenpflicht
Xeloda 1 49 75.00 € pro Patient und vollständig ausgefüllten Beobachtungsplan
Xeloda 57 313 750.00 € durchschnittlich 169,35€ pro Arzt und Jahr
Xeloda 113 n/a 650.00 € max.
Xeloda 205 1,485 n/a Meldung vor Anzeigenpflicht

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.